Literature DB >> 18925988

Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults.

J H Flory1, M Joffe, N O Fishman, P H Edelstein, J P Metlay.   

Abstract

Demographic and clinical risk factors are important in guiding vaccination policy for pneumococcal pneumonia. We present data on these variables from a population-based surveillance network covering adult bacteraemic pneumococcal pneumonia (BPP) in the Delaware Valley region from 2002 to 2004. Surveillance data were used with U.S. Census data and a community health survey to calculate stratified incidence rates. Missing data were handled using multiple imputation. Overall rates of adult BPP were 10.6 cases/100 000 person-years. Elevated rates were seen in the elderly (>65 years), Native Americans, African Americans, the less-educated (less than high-school education), the poor, smokers, and individuals with histories of asthma, cancer, or diabetes. Multivariable modelling suggested that income was more robustly associated with risk than African American race. Of methodological interest, this association was not apparent if census block-group median income was used as a proxy for self-reported income. Further research on socioeconomic risk factors for BPP is needed.

Entities:  

Mesh:

Year:  2008        PMID: 18925988      PMCID: PMC2741180          DOI: 10.1017/S0950268808001489

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  18 in total

1.  From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage--Advisory Committee on Immunization Practices.

Authors: 
Journal:  JAMA       Date:  2002-02-20       Impact factor: 56.272

2.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Authors:  K A Robinson; W Baughman; G Rothrock; N L Barrett; M Pass; C Lexau; B Damaske; K Stefonek; B Barnes; J Patterson; E R Zell; A Schuchat; C G Whitney
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

3.  Cost-benefit analysis of a new HEDIS performance measure for pneumococcal vaccination.

Authors:  Faruque Ahmed; Elamin E Elbasha; Betsy L Thompson; Jeffrey R Harris; Vishnu-Priya Sneller
Journal:  Med Decis Making       Date:  2002 Sep-Oct       Impact factor: 2.583

4.  Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.

Authors:  J P Nuorti; J C Butler; M M Farley; L H Harrison; A McGeer; M S Kolczak; R F Breiman
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

5.  Asthma as a risk factor for invasive pneumococcal disease.

Authors:  Thomas R Talbot; Tina V Hartert; Ed Mitchel; Natasha B Halasa; Patrick G Arbogast; Katherine A Poehling; William Schaffner; Allen S Craig; Marie R Griffin
Journal:  N Engl J Med       Date:  2005-05-19       Impact factor: 91.245

6.  Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

Authors:  Moe H Kyaw; Ruth Lynfield; William Schaffner; Allen S Craig; James Hadler; Arthur Reingold; Ann R Thomas; Lee H Harrison; Nancy M Bennett; Monica M Farley; Richard R Facklam; James H Jorgensen; John Besser; Elizabeth R Zell; Anne Schuchat; Cynthia G Whitney
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

7.  Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults.

Authors:  Joshua P Metlay; Neil O Fishman; Marshall Joffe; Paul H Edelstein
Journal:  Vaccine       Date:  2005-08-15       Impact factor: 3.641

8.  Variation in public and private supply of pneumococcal conjugate vaccine during a shortage.

Authors:  Gary L Freed; Matthew M Davis; Sarah J Clark
Journal:  JAMA       Date:  2003-02-05       Impact factor: 56.272

9.  Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study.

Authors:  Reimar Wernich Thomsen; Heidi Holmager Hundborg; Hans-Henrik Lervang; Søren Paaske Johnsen; Henrik Carl Schønheyder; Henrik Toft Sørensen
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

10.  Macrolide resistance in adults with bacteremic pneumococcal pneumonia.

Authors:  Joshua P Metlay; Neil O Fishman; Marshall M Joffe; Michael J Kallan; Jesse L Chittams; Paul H Edelstein
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

View more
  24 in total

1.  Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults.

Authors:  Deron C Burton; Brendan Flannery; Nancy M Bennett; Monica M Farley; Ken Gershman; Lee H Harrison; Ruth Lynfield; Susan Petit; Arthur L Reingold; William Schaffner; Ann Thomas; Brian D Plikaytis; Charles E Rose; Cynthia G Whitney; Anne Schuchat
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

2.  Defining Sepsis Mortality Clusters in the United States.

Authors:  Justin Xavier Moore; John P Donnelly; Russell Griffin; George Howard; Monika M Safford; Henry E Wang
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

3.  Increased risk of pertussis in patients with asthma.

Authors:  Conrad R Capili; Allison Hettinger; Natalie Rigelman-Hedberg; Lisa Fink; Thomas Boyce; Brian Lahr; Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

4.  Geographic Variation in Hospitalization for Lower Respiratory Tract Infections Across One County.

Authors:  Andrew F Beck; Todd A Florin; Suzanne Campanella; Samir S Shah
Journal:  JAMA Pediatr       Date:  2015-09       Impact factor: 16.193

5.  Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel.

Authors:  Dan Yamin; Ran D Balicer; Alison P Galvani
Journal:  Vaccine       Date:  2014-06-12       Impact factor: 3.641

6.  Socioeconomic Position and the Incidence, Severity, and Clinical Outcomes of Hospitalized Patients With Community-Acquired Pneumonia.

Authors:  Timothy L Wiemken; Ruth M Carrico; Stephen P Furmanek; Brian E Guinn; William A Mattingly; Paula Peyrani; Julio A Ramirez
Journal:  Public Health Rep       Date:  2020-03-31       Impact factor: 2.792

7.  Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies.

Authors:  K A Feemster; Y Li; A R Localio; J Shults; P Edelstein; E Lautenbach; T Smith; J P Metlay
Journal:  Epidemiol Infect       Date:  2012-10-31       Impact factor: 2.451

8.  Electronic Cigarette (E-Cigarette) Vapor Exposure Alters the Streptococcus pneumoniae Transcriptome in a Nicotine-Dependent Manner without Affecting Pneumococcal Virulence.

Authors:  Kamal Bagale; Santosh Paudel; Hayden Cagle; Erin Sigel; Ritwij Kulkarni
Journal:  Appl Environ Microbiol       Date:  2020-01-21       Impact factor: 4.792

9.  Pneumococcal Vaccination Among Adults With Work-related Asthma.

Authors:  Katelynn E Dodd; Jacek M Mazurek
Journal:  Am J Prev Med       Date:  2017-09-27       Impact factor: 5.043

10.  Community characteristics and regional variations in sepsis.

Authors:  Justin Xavier Moore; John P Donnelly; Russell Griffin; Monika M Safford; George Howard; John Baddley; Henry E Wang
Journal:  Int J Epidemiol       Date:  2017-10-01       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.